Fetal blood sampling

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 3, 2013, Pages 170-180

  Berry, Stanley M ^a   Stone, Joanne ^a   Norton, Mary E ^a   Johnson, Donna ^a   Berghella, Vincenzo ^a  

^a Society for Maternal Fetal Medicine   (United States)

Author keywords

cordocentesis; fetal blood sampling; indications; percutaneous umbilical cord blood sampling; risks technical aspects

Indexed keywords

ARTICLE; BLOOD SAMPLING; CORDOCENTESIS; ECHOGRAPHY; EVALUATION; FETAL BLOOD SAMPLING; FETUS ANEMIA; FETUS BRADYCARDIA; FETUS DISEASE; FETUS THROMBOCYTOPENIA; HEALTH CARE ORGANIZATION; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; VERTICAL TRANSMISSION;

CORDOCENTESIS; FETAL BLOOD SAMPLING; INDICATIONS; PERCUTANEOUS UMBILICAL CORD BLOOD SAMPLING; RISKS; TECHNICAL ASPECTS;

ANESTHESIA, LOCAL; ANTIBIOTIC PROPHYLAXIS; CORDOCENTESIS; FEMALE; HUMANS; PREGNANCY;

EID: 84883139158     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.07.014     Document Type: Article

References (74)

1. J. Bang, J.E. Bock, and D. Trolle Ultrasound-guided fetal intravenous transfusion for severe rhesus hemolytic disease Br Med J (Clin Res Ed) 284 1982 373 374 Level III
2. F. Daffos, M. Capella-Pavlovsky, and F. Forestier A new procedure for fetal blood sampling in utero: preliminary results of fifty-three cases Am J Obstet Gynecol 146 1983 985 987 Level II-3
3. A.W. Liley Intrauterine transfusion of fetus in hemolytic disease Br Med J 2 1963 1107 1109 Level III
4. C.H. Rodeck, and S. Campbell Umbilical-cord insertion as source of pure fetal blood for prenatal diagnosis Lancet 1 1979 1244 1245 Level III
5. M. Hansmann, U. Gembruch, R. Bald, M. Manz, and D.A. Redel Fetal tachyarrhythmias: transplacental and direct treatment of the fetus-a report of 60 cases Ultrasound Obstet Gynecol 1 1991 162 168 Level II-3
6. G. Blanch, S.A. Walkinshaw, and K. Walsh Cardioversion of fetal tachyarrhythmia with adenosine Lancet 344 1994 1646 Level III
7. M.L. Denbow, M.J. Blomley, D.O. Cosgrove, and N.M. Fisk Ultrasound microbubble contrast angiography in monochorionic twin fetuses Lancet 349 1997 773 Level III
8. S.M. Berry, N. Fine, J.A. Bichalski, D.B. Cotton, M.P. Dombrowski, and J. Kaplan Circulating lymphocyte subsets in second- and third-trimester fetuses: comparison with newborns and adults Am J Obstet Gynecol 167 1992 895 900 Level II-3
9. S.M. Berry, B. Lecolier, and R.S. Smith Predictive value of fetal serum beta 2-microglobulin for neonatal renal function Lancet 345 1995 1277 1278 Level II-2
10. B.M. Tassis, L. Trespidi, A.S. Tirelli, E. Pace, C. Boschetto, and U. Nicolini Serum beta 2-microglobulin in fetuses with urinary tract anomalies Am J Obstet Gynecol 176 1997 54 57 Level II-1
11. J.G. Thorpe-Beeston, and K.H. Nicolaides Fetal thyroid function Fetal Diagn Ther 8 1993 60 72 Level III
12. S.M. Geaghan Fetal laboratory medicine: on the frontier of maternal-fetal medicine Clin Chem 58 2012 337 352 Level III
13. C. Gosden, C.H. Rodeck, K.H. Nicolaides, S. Campbell, P. Eason, and J.C. Sharp Fetal blood chromosome analysis: some new indications for prenatal karyotyping Br J Obstet Gynaecol 92 1985 915 920 Level II-2
14. G. Mari, R.L. Deter, and R.L. Carpenter Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization; collaborative group for Doppler assessment of the blood velocity in anemic fetuses N Engl J Med 342 2000 9 14 Level II-3
15. V.J. Freda, J.G. Gorman, and W. Pollack Rh factor: prevention of isoimmunization and clinical trial on mothers Science 151 1966 828 830 Level II-1
16. C.A. Crowther, and M.J. Keirse Anti-D administration in pregnancy for preventing rhesus alloimmunization Cochrane Database Syst Rev 2 2000 CD000020 Level III
17. J. Chilcott, M. Lloyd Jones, and J. Wight A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative Health Technol Assess 7 2003 iii 62 Level III
18. C. Johnstone-Ayliffe, T. Prior, C. Ong, F. Regan, and S. Kumar Early procedure-related complications of fetal blood sampling and intrauterine transfusion for fetal anemia Acta Obstet Gynecol Scand 91 2012 458 462 Level II-2
19. K.H. Nicolaides, B. Thilaganathan, C.H. Rodeck, and R.S. Mibashan Erythroblastosis and reticulocytosis in anemic fetuses Am J Obstet Gynecol 159 1988 1063 1065 Level II-2
20. J.B. Bussel, R.L. Berkowitz, and C. Hung Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus Am J Obstet Gynecol 203 2010 135.e1 135.e14 Level II-2
21. Z.K. McQuilten, E.M. Wood, H. Savoia, and S. Cole A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry Aust N Z J Obstet Gynaecol 51 2011 191 198 Level III
22. C. Bellini, R.C. Hennekam, and E. Fulcheri Etiology of nonimmune hydrops fetalis: a systematic review Am J Med Genet A 149A 2009 844 851 Level III
23. S. Santo, S. Mansour, and B. Thilaganathan Prenatal diagnosis of non-immune hydrops fetalis: what do we tell the parents? Prenat Diagn 31 2011 186 195 Level II-2
24. L.Y. Hsu, and P.A. Benn Revised guidelines for the diagnosis of mosaicism in amniocytes Prenat Diagn 19 1999 1081 1082 Level III
25. N.M. Fisk, P. Bennett, and R.M. Warwick Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi Am J Obstet Gynecol 171 1994 50 54 Level II-3
26. S. Simsek, G.C. Christiaens, and H.H. Kanhai Human platelet antigen-1 (Zw) typing of fetuses by analysis of polymerase chain reaction-amplified genomic DNA from amniocytes Transfus Med 4 1994 15 19 Level III
27. S.P. Muller, I. Bartels, and W. Stein The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible Transfusion 48 2008 2292 2301 Level II-2
28. K. Finning, P. Martin, J. Summers, E. Massey, G. Poole, and G. Daniels Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study BMJ 336 2008 816 818 Level II-2
29. C.F. Wright, and H. Burton The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis Hum Reprod Update 15 2009 139 151 Level III
30. C.E. van der Schoot, S. Hahn, and L.S. Chitty Non-invasive prenatal diagnosis and determination of fetal Rh status Semin Fetal Neonatal Med 13 2008 63 68 Level III
31. T.Y. Leung, and T.T. Lao Thalassemia in pregnancy Best Pract Res Clin Obstet Gynaecol 26 2012 37 51 Level III
32. S.J. Dwinnell, S. Coad, and B. Butler In utero diagnosis and management of a fetus with homozygous alpha-thalassemia in the second trimester: a case report and literature review J Pediatr Hematol Oncol 33 2011 e358 e360 Level III
33. K. Boupaijit, C. Wanapirak, W. Piyamongkol, S. Sirichotiyakul, and T. Tongsong Effect of placenta penetration during cordocentesis at mid-pregnancy on fetal outcomes Prenat Diagn 32 2012 83 87 Level II-2
34. A. Corbacioglu Esmer, A. Gul, H. Dagdeviren, I. Turan Bakirci, and O. Sahin Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism J Obstet Gynaecol Res 39 2013 720 723 Level III
35. S. Bliddal, A.K. Rasmussen, K. Sundberg, V. Brocks, P. Skovbo, and U. Feldt-Rasmussen Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine Thyroid 21 2011 75 81 Level III
36. A.L. Freedman, T.P. Bukowski, and C.A. Smith Use of urinary beta-2-microglobulin to predict severe renal damage in fetal obstructive uropathy Fetal Diagn Ther 12 1997 1 6 Level II-2
37. M.R. Haddad, C.J. Macri, and C.S. Holmes In utero copper treatment for Menkes disease associated with a severe ATP7A mutation Mol Genet Metab 107 2012 222 228 Level III
38. M.A. Sanchez, J.C. Bello-Munoz, and I. Cebrecos The prevalence of congenital varicella syndrome after a maternal infection, but before 20 weeks of pregnancy: a prospective cohort study J Matern Fetal Neonatal Med 24 2011 341 347 Level II-2
39. V. Tomek, J. Marek, and I. Spalova Intraumbilical therapy of fetal supraventricular tachycardia Ceska Gynekol 67 2002 380 383 Level III
40. J.H. Dangel, T. Roszkowski, K. Bieganowska, K. Kubicka, and J. Ganowicz Adenosine triphosphate for cardioversion of supraventricular tachycardia in two hydropic fetuses Fetal Diagn Ther 15 2000 326 330 Level III
41. M. Tchirikov, O. Kharkevich, J. Steetskamp, M. Beluga, and M. Strohner Treatment of growth-restricted human fetuses with amino acids and glucose supplementation through a chronic fetal intravascular perinatal port system Eur Surg Res 45 2010 45 49 Level III
42. N.M. Fisk, R. Gitau, J.M. Teixeira, X. Giannakoulopoulos, A.D. Cameron, and V.A. Glover Effect of direct fetal opioid analgesia on fetal hormonal and hemodynamic stress response to intrauterine needling Anesthesiology 95 2001 828 835 Level II-3
43. C. Tangshewinsirikul, C. Wanapirak, W. Piyamongkol, S. Sirichotiyakul, and T. Tongsong Effect of cord puncture site in cordocentesis at mid-pregnancy on pregnancy outcomes Prenat Diagn 31 2011 861 864 Level II-2
44. T. Tongsong, C. Wanapirak, C. Kunavikatikul, S. Sirirchotiyakul, W. Piyamongkol, and P. Chanprapaph Cordocentesis at 16-24 weeks of gestation: experience of 1,320 cases Prenat Diagn 20 2000 224 228 Level II-2
45. A.J. Aina-Mumuney, C.J. Holcroft, and K.J. Blakemore Intrahepatic vein for fetal blood sampling: one center's experience Am J Obstet Gynecol 198 2008 387.e1 387.e6 Level II-2
46. U. Nicolini, P. Nicolaidis, N.M. Fisk, Y. Tannirandorn, and C.H. Rodeck Fetal blood sampling from the intrahepatic vein: analysis of safety and clinical experience with 214 procedures Obstet Gynecol 76 1990 47 53 Level II-2
47. D.A. Somerset, A. Moore, M.J. Whittle, W. Martin, and M.D. Kilby An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis Fetal Diagn Ther 21 2006 272 276 Level II-2
48. J. Sikovanyecz, E. Horvath, E. Sallay, J. Gellen, A. Pal, and J. Szabo Fetomaternal transfusion and pregnancy outcome after cordocentesis Fetal Diagn Ther 16 2001 83 89 Level II-2
49. C. Liao, J. Wei, Q. Li, L. Li, J. Li, and D. Li Efficacy and safety of cordocentesis for prenatal diagnosis Int Gynecol Obstet 93 2006 13 17 Level II-2
50. P. Boulot, F. Deschamps, and G. Lefort Pure fetal blood samples obtained by cordocentesis: technical aspects of 322 cases Prenat Diagn 10 1990 93 100 Level II-2
51. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 88, December 2007: invasive prenatal testing for aneuploidy Obstet Gynecol 110 2007 1459 1467 Level III
52. L.D. Pacheco, R.L. Berkowitz, K.J. Moise Jr., J.B. Bussel, J.G. McFarland, and G.R. Saade Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification Obstet Gynecol 118 2011 1157 1163 Level III
53. A.P. Sarno Jr., and R.D. Wilson Fetal cardiocentesis: a review of indications, risks, applications and technique Fetal Diagn Ther 23 2008 237 244 Level III
54. A. Chinnaiya, A. Venkat, and C. Dawn Intrahepatic vein fetal blood sampling: current role in prenatal diagnosis J Obstet Gynaecol Res 24 1998 239 246 Level II-2
55. C.P. Weiner, K.D. Wenstrom, S.L. Sipes, and R.A. Williamson Risk factors for cordocentesis and fetal intravascular transfusion Am J Obstet Gynecol 165 1991 1020 1025 Level II-2
56. J.A. Copel, P.A. Grannum, D. Harrison, and J.C. Hobbins The use of intravenous pancuronium bromide to produce fetal paralysis during intravascular transfusion Am J Obstet Gynecol 158 1988 170 171 Level III
57. K.J. Moise Jr., R.L. Deter, B. Kirshon, K. Adam, D.E. Patton, and R.J. Carpenter Jr. Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red-cell alloimmunization Obstet Gynecol 74 1989 905 908 Level II-2
58. H.H. Bernstein, U. Chitkara, H. Plosker, M. Gettes, and R.L. Berkowitz Use of atracurium besylate to arrest fetal activity during intrauterine intravascular transfusions Obstet Gynecol 72 1988 813 816 Level II-3
59. C. Leveque, I. Murat, F. Toubas, M.H. Poissonnier, Y. Brossard, and C. Saint-Maurice Fetal neuromuscular blockade with vecuronium bromide: studies during intravascular intrauterine transfusion in isoimmunized pregnancies Anesthesiology 76 1992 642 644 Level III
60. R.J. Mouw, F. Klumper, J. Hermans, H.C. Brandenburg, and H.H. Kanhai Effect of atracurium or pancuronium on the anemic fetus during and directly after intravascular intrauterine transfusion: a double blind randomized study Acta Obstet Gynecol Scand 78 1999 763 767 Level I
61. D.J. Chapple, and J.S. Clark Pharmacological action of breakdown products of atracurium and related substances Br J Anaesth 55 Suppl 1983 11 15S Level III
62. Y. Ville, M. Cooper, A. Revel, R. Frydman, and K.H. Nicolaides Development of a training model for ultrasound-guided invasive procedures in fetal medicine Ultrasound Obstet Gynecol 5 1995 180 183 Level III
63. F. Tongprasert, C. Wanapirak, S. Sirichotiyakul, W. Piyamongkol, and T. Tongsong Training in cordocentesis: the first 50 case experience with and without a cordocentesis training model Prenat Diagn 30 2010 467 470 Level II-2
64. J.Y. Han, and A.A. Nava-Ocampo Fetal heart rate response to cordocentesis and pregnancy outcome: a prospective cohort J Matern Fetal Neonatal Med 17 2005 207 211 Level II-2
65. D.J. Maxwell, P. Johnson, P. Hurley, K. Neales, L. Allan, and P. Knott Fetal blood sampling and pregnancy loss in relation to indication Br J Obstet Gynaecol 98 1991 892 897 Level II-3
66. T. Tongsong, C. Wanapirak, C. Kunavikatikul, S. Sirirchotiyakul, W. Piyamongkol, and P. Chanprapaph Fetal loss rate associated with cordocentesis at midgestation Am J Obstet Gynecol 184 2001 719 723 Level II-2
67. T.M. Ko, L.H. Tseng, and M.H. Chang Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection Arch Gynecol Obstet 255 1994 25 30 Level II-2
68. J.M. Alexander, R. Ramus, G. Jackson, B. Sercely, and G.D. Wendel Jr. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers Infect Dis Obstet Gynecol 7 1999 283 286 Level II-2
69. C. Delamare, B. Carbonne, and N. Heim Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study J Hepatol 31 1999 416 420 Level II-2
70. E. Somigliana, A.M. Bucceri, and C. Tibaldi Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series Am J Obstet Gynecol 193 2005 437 442 Level III
71. C.V. Towers, T. Asrat, and P. Rumney The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood Am J Obstet Gynecol 184 2001 1514 1520 Level II-2
72. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. HIV infected women. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf. Accessed Aug. 7, 2013. Level III.
73. G.H. Guyatt, A.D. Oxman, G. Vist for the GRADE Working Group Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926 Level III
74. UpToDate, grading guide. Available at: http://www.uptodate.com/home/ grading-guide#GradingRecommendations. Accessed March 10, 2013. Level III.